doi: 10.1001/jamainternmed.2019.1291.
Sodium Polystyrene Sulfonate for Hyperkalemia
Affiliations
- PMID: 31180445
- DOI: 10.1001/jamainternmed.2019.1291
Item in Clipboard
Sodium Polystyrene Sulfonate for Hyperkalemia
JAMA Intern Med.
.
No abstract available
Comment in
-
An Alternative to Sodium Polystyrene Sulfonate and Patiromer for the Treatment of Hyperkalemia.JAMA Intern Med. 2019 Nov 1;179(11):1600. doi: 10.1001/jamainternmed.2019.4698. JAMA Intern Med. 2019. PMID: 31682691 No abstract available.
-
An Alternative to Sodium Polystyrene Sulfonate and Patiromer for the Treatment of Hyperkalemia-Reply.JAMA Intern Med. 2019 Nov 1;179(11):1600-1601. doi: 10.1001/jamainternmed.2019.4685. JAMA Intern Med. 2019. PMID: 31682699 No abstract available.
Similar articles
-
Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD.Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2136-42. doi: 10.2215/CJN.03640415. Epub 2015 Nov 17. Clin J Am Soc Nephrol. 2015. PMID: 26576619 Free PMC article. Clinical Trial.
-
Cost-utility analysis of sodium polystyrene sulfonate vs. potential alternatives for chronic hyperkalemia.Clin Nephrol. 2014 Apr;81(4):259-68. doi: 10.5414/cn108103. Clin Nephrol. 2014. PMID: 24656316
-
Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age.JAMA Intern Med. 2019 Aug 1;179(8):1025-1033. doi: 10.1001/jamainternmed.2019.0631. JAMA Intern Med. 2019. PMID: 31180477 Free PMC article.
-
Gastrointestinal adverse events with sodium polystyrene sulfonate (Kayexalate) use: a systematic review.Am J Med. 2013 Mar;126(3):264.e9-24. doi: 10.1016/j.amjmed.2012.08.016. Epub 2013 Jan 12. Am J Med. 2013. PMID: 23321430 Review.
-
Cecal perforation associated with sodium polystyrene sulfonate-sorbitol enemas in a 650 gram infant with hyperkalemia.Am J Perinatol. 1996 Apr;13(3):167-70. doi: 10.1055/s-2007-994318. Am J Perinatol. 1996. PMID: 8688109 Review.
Cited by
-
Hyperkalaemia in Cardiological Patients: New Solutions for an Old Problem.Cardiovasc Drugs Ther. 2024 Jan 30. doi: 10.1007/s10557-024-07551-7. Online ahead of print. Cardiovasc Drugs Ther. 2024. PMID: 38289453 Review.
-
Recent Progresses in Non-Dialysis Chronic Kidney Disease Patients with Hyperkalemia: Outcomes and Therapeutic Strategies.Medicina (Kaunas). 2023 Feb 13;59(2):353. doi: 10.3390/medicina59020353. Medicina (Kaunas). 2023. PMID: 36837554 Free PMC article. Review.
-
Treatment of Mild Hyperkalemia in Hospitalized Patients: An Unnecessary Practice?Can J Hosp Pharm. 2021 Summer;74(3):269-276. doi: 10.4212/cjhp.v74i3.3154. Epub 2021 Jul 1. Can J Hosp Pharm. 2021. PMID: 34248167 Free PMC article.
-
The dietary management of potassium in children with CKD stages 2-5 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce.Pediatr Nephrol. 2021 Jun;36(6):1331-1346. doi: 10.1007/s00467-021-04923-1. Epub 2021 Mar 17. Pediatr Nephrol. 2021. PMID: 33730284 Free PMC article. Review.
-
New Treatment Options for Hyperkalemia in Patients with Chronic Kidney Disease.J Clin Med. 2020 Jul 22;9(8):2337. doi: 10.3390/jcm9082337. J Clin Med. 2020. PMID: 32707890 Free PMC article. Review.
LinkOut - more resources
Full Text Sources
